Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study

ABSTRACT: Background: Cervical cytology remains widely used as the initial tool in cervical cancer screening worldwide. WHO guidelines recommend replacing cytology with primary HPV testing to reach cervical cancer elimination goals. We assessed the performance of cytology and high-risk HPV testing t...

Full description

Autores:
Ramírez Pineda, Arianis Tatiana
Valencia Arredondo, Marleny
Rojas, Freddy David
Ramírez, Katherine
Álvarez, Rodrigo
Cristaldo, Carmen
Henríquez, Odessa
Moreno, Adrián
Colque Reynaga, Daysi Colque
González Palma, Hans
Robinson, Isabel
Hernández, Diana Carolina
Bardales, Rosa
Cardinal, Lucia
Salgado, Yuly
Martínez, Sandra
González, Emmanuel
Guillén, Diego
Fleider, Laura
Tatti, Silvio
Villagra, Verónica
Venegas, Gino
Cruz Valdez, Aurelio
Valls, Joan
Rodríguez, Guillermo
Terán, Carolina
Picconi, María Alejandra
Ferrera, Annabelle
Kasamatsu, Elena
Mendoza, Laura
Calderon, Alejandro
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Almonte, Maribel
Herrero, Rolando
Baena Zapata, Armando
Sánchez Vásquez, Gloria
Tipo de recurso:
Article of investigation
Fecha de publicación:
2023
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/45227
Acceso en línea:
https://hdl.handle.net/10495/45227
Palabra clave:
Citología
Cytology
Tamizaje Masivo
Mass Screening
Virus del Papiloma Humano
Human Papillomavirus Viruses
https://id.nlm.nih.gov/mesh/D000093222
https://id.nlm.nih.gov/mesh/D008403
https://id.nlm.nih.gov/mesh/D000094302
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id UDEA2_e4a21943ac7f9e328148c9f802809d7e
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/45227
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
title Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
spellingShingle Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
Citología
Cytology
Tamizaje Masivo
Mass Screening
Virus del Papiloma Humano
Human Papillomavirus Viruses
https://id.nlm.nih.gov/mesh/D000093222
https://id.nlm.nih.gov/mesh/D008403
https://id.nlm.nih.gov/mesh/D000094302
title_short Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
title_full Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
title_fullStr Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
title_full_unstemmed Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
title_sort Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
dc.creator.fl_str_mv Ramírez Pineda, Arianis Tatiana
Valencia Arredondo, Marleny
Rojas, Freddy David
Ramírez, Katherine
Álvarez, Rodrigo
Cristaldo, Carmen
Henríquez, Odessa
Moreno, Adrián
Colque Reynaga, Daysi Colque
González Palma, Hans
Robinson, Isabel
Hernández, Diana Carolina
Bardales, Rosa
Cardinal, Lucia
Salgado, Yuly
Martínez, Sandra
González, Emmanuel
Guillén, Diego
Fleider, Laura
Tatti, Silvio
Villagra, Verónica
Venegas, Gino
Cruz Valdez, Aurelio
Valls, Joan
Rodríguez, Guillermo
Terán, Carolina
Picconi, María Alejandra
Ferrera, Annabelle
Kasamatsu, Elena
Mendoza, Laura
Calderon, Alejandro
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Almonte, Maribel
Herrero, Rolando
Baena Zapata, Armando
Sánchez Vásquez, Gloria
dc.contributor.author.none.fl_str_mv Ramírez Pineda, Arianis Tatiana
Valencia Arredondo, Marleny
Rojas, Freddy David
Ramírez, Katherine
Álvarez, Rodrigo
Cristaldo, Carmen
Henríquez, Odessa
Moreno, Adrián
Colque Reynaga, Daysi Colque
González Palma, Hans
Robinson, Isabel
Hernández, Diana Carolina
Bardales, Rosa
Cardinal, Lucia
Salgado, Yuly
Martínez, Sandra
González, Emmanuel
Guillén, Diego
Fleider, Laura
Tatti, Silvio
Villagra, Verónica
Venegas, Gino
Cruz Valdez, Aurelio
Valls, Joan
Rodríguez, Guillermo
Terán, Carolina
Picconi, María Alejandra
Ferrera, Annabelle
Kasamatsu, Elena
Mendoza, Laura
Calderon, Alejandro
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Almonte, Maribel
Herrero, Rolando
Baena Zapata, Armando
Sánchez Vásquez, Gloria
dc.contributor.researchgroup.spa.fl_str_mv Infección y Cáncer
dc.subject.decs.none.fl_str_mv Citología
Cytology
Tamizaje Masivo
Mass Screening
Virus del Papiloma Humano
Human Papillomavirus Viruses
topic Citología
Cytology
Tamizaje Masivo
Mass Screening
Virus del Papiloma Humano
Human Papillomavirus Viruses
https://id.nlm.nih.gov/mesh/D000093222
https://id.nlm.nih.gov/mesh/D008403
https://id.nlm.nih.gov/mesh/D000094302
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D000093222
https://id.nlm.nih.gov/mesh/D008403
https://id.nlm.nih.gov/mesh/D000094302
description ABSTRACT: Background: Cervical cytology remains widely used as the initial tool in cervical cancer screening worldwide. WHO guidelines recommend replacing cytology with primary HPV testing to reach cervical cancer elimination goals. We assessed the performance of cytology and high-risk HPV testing to detect cervical precancer, cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) among women aged 30-64 years participating in the ESTAMPA study. Methods: Women were screened with cytology and HPV across ESTAMPA study centres in Latin America. Screen-positives were referred to colposcopy with biopsy collection and treatment as needed. Those with no evident precancer were recalled at 18-months for a second HPV test to complete disease ascertainment. Performance indicators for cytology and HPV to detect CIN3+ were estimated. Findings: 30,606 participants with available cytology and HPV results were included in the analysis. A total of 440 histologically confirmed CIN3s and 30 cancers were diagnosed. Cytology sensitivity for CIN3+ was 48.5% (95% CI: 44.0-53.0), whereas HPV testing had a sensitivity of 98.1% (95% CI: 96.3-96.7). Specificity was 96.5% (95% CI: 96.3-96.7) using cytology and 88.7% (95% CI: 88.3-89.0) with HPV. Performance estimates varied substantially by study centre for cytology (ranging from 32.1% to 87.5% for sensitivity and from 89.2% to 99.5% for specificity) while for HPV results were more consistent across sites (96.7%-100% and 83.6-90.8%, respectively). Interpretation: The limited and highly variable sensitivity of cytology strongly supports transition to the more robust and reproducible HPV-based cervical screening to ensure progress towards global cervical cancer elimination targets in Latin America. Funding: IARC/WHO, UNDP, HRP/WHO, NCI and local funders.
publishDate 2023
dc.date.issued.none.fl_str_mv 2023
dc.date.accessioned.none.fl_str_mv 2025-02-26T21:40:17Z
dc.date.available.none.fl_str_mv 2025-02-26T21:40:17Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Ramírez AT, Valls J, Baena A, Rojas FD, Ramírez K, Álvarez R, Cristaldo C, Henríquez O, Moreno A, Reynaga DC, Palma HG, Robinson I, Hernández DC, Bardales R, Cardinal L, Salgado Y, Martínez S, González E, Guillén D, Fleider L, Tatti S, Villagra V, Venegas G, Cruz-Valdez A, Valencia M, Rodríguez G, Terán C, Picconi MA, Ferrera A, Kasamatsu E, Mendoza L, Calderon A, Luciani S, Broutet N, Darragh T, Almonte M, Herrero R; ESTAMPA Study Group. Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study. Lancet Reg Health Am. 2023 Sep 20;26:100593. doi: 10.1016/j.lana.2023.100593.
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/45227
dc.identifier.doi.none.fl_str_mv 10.1016/j.lana.2023.100593
dc.identifier.eissn.none.fl_str_mv 2667-193X
identifier_str_mv Ramírez AT, Valls J, Baena A, Rojas FD, Ramírez K, Álvarez R, Cristaldo C, Henríquez O, Moreno A, Reynaga DC, Palma HG, Robinson I, Hernández DC, Bardales R, Cardinal L, Salgado Y, Martínez S, González E, Guillén D, Fleider L, Tatti S, Villagra V, Venegas G, Cruz-Valdez A, Valencia M, Rodríguez G, Terán C, Picconi MA, Ferrera A, Kasamatsu E, Mendoza L, Calderon A, Luciani S, Broutet N, Darragh T, Almonte M, Herrero R; ESTAMPA Study Group. Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study. Lancet Reg Health Am. 2023 Sep 20;26:100593. doi: 10.1016/j.lana.2023.100593.
10.1016/j.lana.2023.100593
2667-193X
url https://hdl.handle.net/10495/45227
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Lancet. Reg. Health. Am.
dc.relation.citationendpage.spa.fl_str_mv 11
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 26
dc.relation.ispartofjournal.spa.fl_str_mv The Lancet Regional Health Americas
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 11 Páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.place.spa.fl_str_mv Oxford, Inglaterra
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/e7f61bc1-e889-40a2-bf9e-edaa92691cf8/download
https://bibliotecadigital.udea.edu.co/bitstreams/9b615ba3-d5f9-46a5-9231-87ef2589a20d/download
https://bibliotecadigital.udea.edu.co/bitstreams/684657ef-63e3-40ae-abbc-7f9402f6a206/download
https://bibliotecadigital.udea.edu.co/bitstreams/544707c8-41af-4745-a9fd-5840ec50f7c7/download
https://bibliotecadigital.udea.edu.co/bitstreams/47601254-8b6a-4bfc-9262-896f75b82cea/download
bitstream.checksum.fl_str_mv b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
a30a6762d9d0dc21e25c477566e26040
a3ba431040aeb816bc95121f32220661
863d12922a139b321131e2b5a7ce8e29
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052587217846272
spelling Ramírez Pineda, Arianis TatianaValencia Arredondo, MarlenyRojas, Freddy DavidRamírez, KatherineÁlvarez, RodrigoCristaldo, CarmenHenríquez, OdessaMoreno, AdriánColque Reynaga, Daysi ColqueGonzález Palma, HansRobinson, IsabelHernández, Diana CarolinaBardales, RosaCardinal, LuciaSalgado, YulyMartínez, SandraGonzález, EmmanuelGuillén, DiegoFleider, LauraTatti, SilvioVillagra, VerónicaVenegas, GinoCruz Valdez, AurelioValls, JoanRodríguez, GuillermoTerán, CarolinaPicconi, María AlejandraFerrera, AnnabelleKasamatsu, ElenaMendoza, LauraCalderon, AlejandroLuciani, SilvanaBroutet, NathalieDarragh, TeresaAlmonte, MaribelHerrero, RolandoBaena Zapata, ArmandoSánchez Vásquez, GloriaInfección y Cáncer2025-02-26T21:40:17Z2025-02-26T21:40:17Z2023Ramírez AT, Valls J, Baena A, Rojas FD, Ramírez K, Álvarez R, Cristaldo C, Henríquez O, Moreno A, Reynaga DC, Palma HG, Robinson I, Hernández DC, Bardales R, Cardinal L, Salgado Y, Martínez S, González E, Guillén D, Fleider L, Tatti S, Villagra V, Venegas G, Cruz-Valdez A, Valencia M, Rodríguez G, Terán C, Picconi MA, Ferrera A, Kasamatsu E, Mendoza L, Calderon A, Luciani S, Broutet N, Darragh T, Almonte M, Herrero R; ESTAMPA Study Group. Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study. Lancet Reg Health Am. 2023 Sep 20;26:100593. doi: 10.1016/j.lana.2023.100593.https://hdl.handle.net/10495/4522710.1016/j.lana.2023.1005932667-193XABSTRACT: Background: Cervical cytology remains widely used as the initial tool in cervical cancer screening worldwide. WHO guidelines recommend replacing cytology with primary HPV testing to reach cervical cancer elimination goals. We assessed the performance of cytology and high-risk HPV testing to detect cervical precancer, cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) among women aged 30-64 years participating in the ESTAMPA study. Methods: Women were screened with cytology and HPV across ESTAMPA study centres in Latin America. Screen-positives were referred to colposcopy with biopsy collection and treatment as needed. Those with no evident precancer were recalled at 18-months for a second HPV test to complete disease ascertainment. Performance indicators for cytology and HPV to detect CIN3+ were estimated. Findings: 30,606 participants with available cytology and HPV results were included in the analysis. A total of 440 histologically confirmed CIN3s and 30 cancers were diagnosed. Cytology sensitivity for CIN3+ was 48.5% (95% CI: 44.0-53.0), whereas HPV testing had a sensitivity of 98.1% (95% CI: 96.3-96.7). Specificity was 96.5% (95% CI: 96.3-96.7) using cytology and 88.7% (95% CI: 88.3-89.0) with HPV. Performance estimates varied substantially by study centre for cytology (ranging from 32.1% to 87.5% for sensitivity and from 89.2% to 99.5% for specificity) while for HPV results were more consistent across sites (96.7%-100% and 83.6-90.8%, respectively). Interpretation: The limited and highly variable sensitivity of cytology strongly supports transition to the more robust and reproducible HPV-based cervical screening to ensure progress towards global cervical cancer elimination targets in Latin America. Funding: IARC/WHO, UNDP, HRP/WHO, NCI and local funders.COL001232811 Páginasapplication/pdfengElsevierOxford, Inglaterrahttps://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/2.5/co/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionCitologíaCytologyTamizaje MasivoMass ScreeningVirus del Papiloma HumanoHuman Papillomavirus Viruseshttps://id.nlm.nih.gov/mesh/D000093222https://id.nlm.nih.gov/mesh/D008403https://id.nlm.nih.gov/mesh/D000094302Lancet. Reg. Health. Am.11126The Lancet Regional Health AmericasPublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/e7f61bc1-e889-40a2-bf9e-edaa92691cf8/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/9b615ba3-d5f9-46a5-9231-87ef2589a20d/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdfRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdfArtículo de investigaciónapplication/pdf374812https://bibliotecadigital.udea.edu.co/bitstreams/684657ef-63e3-40ae-abbc-7f9402f6a206/downloada30a6762d9d0dc21e25c477566e26040MD51trueAnonymousREADTEXTRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdf.txtRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdf.txtExtracted texttext/plain61065https://bibliotecadigital.udea.edu.co/bitstreams/544707c8-41af-4745-a9fd-5840ec50f7c7/downloada3ba431040aeb816bc95121f32220661MD54falseAnonymousREADTHUMBNAILRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdf.jpgRamirezArianis_2023_ Performance_Cervical_Cytology_HPV.pdf.jpgGenerated Thumbnailimage/jpeg14787https://bibliotecadigital.udea.edu.co/bitstreams/47601254-8b6a-4bfc-9262-896f75b82cea/download863d12922a139b321131e2b5a7ce8e29MD55falseAnonymousREAD10495/45227oai:bibliotecadigital.udea.edu.co:10495/452272025-03-27 00:41:21.264https://creativecommons.org/licenses/by-nc-nd/4.0/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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